Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00051
|
|||||
| Drug Name |
Levalbuterol
|
|||||
| Synonyms |
(-)-alpha(sup 1)-(((1,1-Dimethylethyl)amino)methyl)-4-hydroxy-1,3-benzenedimethanol; (R)-albuterol; (R)-salbutamol; (r)-(-)-salbutamol; 34391-04-3; 4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol; CHEBI:8746; EDN2NBH5SS; Levosalbutamol; Levosalbutamol (INN); Levosalbutamol [INN]; R-Albuterol; R-Salbutamol; UNII-EDN2NBH5SS; Xopenex; m-Xylene-alpha,alpha'-diol, alpha(sup 1)-((tert-butylamino)methyl)-4-hydroxy-, (R)-(-)-
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C13H21NO3
|
|||||
| Canonical SMILES |
CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
|
|||||
| InChI |
InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3/t12-/m0/s1
|
|||||
| InChIKey |
NDAUXUAQIAJITI-LBPRGKRZSA-N
|
|||||
| CAS Number |
CAS 149234-08-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 239.31 | Topological Polar Surface Area | 72.7 | ||
| Heavy Atom Count | 17 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
0.3
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10240794
, 103266935
, 103911314
, 104418876
, 10852016
, 11111805
, 11111806
, 11112645
, 11113612
, 117814444
, 124881447
, 125325478
, 126524239
, 126670038
, 128684762
, 131311264
, 131835145
, 135078939
, 135376066
, 136965309
, 137001318
, 139121247
, 13934
, 14798337
, 164795671
, 175267044
, 175269554
, 177748808
, 179150348
, 184546277
, 223519271
, 223668238
, 223982365
, 226396078
, 252091683
, 252166097
, 26744252
, 29303834
, 49879812
, 50071332
, 57340474
, 77876163
, 93166666
, 96024814
, 99036159
, 99234398
, 99774850
|
|||||
| ChEBI ID |
ChEBI:8746
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.